Back to search
FDAFDA · Food and drugs·Recall number D-0657-2026

Synjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets), 12.5/1000 mg, 60 Tablets per Bottle, Rx only, Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 USA. NDC: 00597-0300-45

Published July 8, 2026 · Recall initiated: June 12, 2026

Summary

FDA records drug Class II recall D-0657-2026, published July 8, 2026 and initiated June 12, 2026. Recalling firm: Boehringer Ingelheim Pharmaceuticals, Inc.; Status: Ongoing; Reported quantity: 560 bottles; Lot: Lot 3244413; Exp. 12/31/2028. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been used for a different product.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Boehringer Ingelheim Pharmaceuticals, Inc.
Distributor
OH
Lot
Lot 3244413; Exp. 12/31/2028
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Synjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets), 12.5/1000 mg, 60 Tablets per Bottle, Rx only, Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 USA. NDC: 00597-0300-45 recalled?

Yes. FDA published recall D-0657-2026 on July 8, 2026. Reported hazard: CGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been used for a different product.

What should I do if I have this product?

Voluntary: Firm initiated · Letter